Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma

Journal of Hepatology

Volumn 39, Issue 4, 2003, Pages 559-563

  Watanabe, Hironobu ^a   Enjoji, Munechika ^a   Nakashima, Manabu ^a   Noguchi, Ken Ichi ^a   Kinukawa, Naoko ^b   Sugimoto, Rie ^a   Kotoh, Kazuhiro ^a   Nakamuta, Makoto ^a   Nawata, Hajime ^a   Watanabe, Takeshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

CA19 9; Cholangiocellular carcinoma; RCAS1; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MONOCLONAL ANTIBODY; RCAS1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BILE DUCT CARCINOMA; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATOBILIARY DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 12444315017     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00363-5     Document Type: Article

References (14)

1. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996;77:1501-1509.
2. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 1998;4:1517-1520.
3. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, et al. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000;89:488-493.
4. Izumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001;92:446-451.
5. Takahashi H, Iizuka H, Nakashima M, Wada T, Asano K, Ishida-Yamamoto A, et al. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001;26:140-144.
6. Noguchi K, Enjoji M, Nakamuta M, Nakashima M, Nishi H, Choi I, et al. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001;168:197-202.
7. Kubokawa M, Nakashima M, Yao T, Ito K, Harada N, Nawata H, et al. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001;19:695-700.
8. Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, et al. The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of the biliary tract. J Hepatol 2002;36:786-792.
9. Enjoji M, Nakamuta M, Noguchi K, Sugimoto R, Kotoh K, Nawata H, et al. RCAS1 expression in immune-mediated liver diseases. J Clin Gastroenterol 2002;34:286-287.
10. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nature Med 1999;5:938-942.
11. Ritts RE, Del Villano BC, Go VLW, Herberman RB, Klug TL, Zurawski Jr VR. Initial clinical evaluation of an immunoradiometric assay for CA19-9 using the NCI serum bank. Int J Cancer 1984;33:339-345.
12. Jalanko H, Kuusera P, Roberts P, Sipponen P, Haglund CA, Makela O. Comparison of a new tumor marker, CA19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 1984;37:218-222.
13. Steinberg W. The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-355.
14. Ker CG, Chen JS, Lee KT, Sheen PC, Wu CC. Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma. J Gastroenterol Hepatol 1991;6:505-508.